Skip to main content

Table 1 Characteristics of the HCV genotype 1 and 2 infected patients with PEG-IFNα-RBV therapy

From: Association of MRC-1 and IL-28Bwith the treatment outcome of hepatitis C: a case control study

 

HCV genotype 1 (HCV-1)

HCV genotype 2 (HCV-2)

 

All

SVR (+)

SVR (−)

Pvalue

All

SVR (+)

SVR (−)

Pvalue

Number of patients

265

163

102

-

195

178

17

-

Sex (male/female)

129/136

84/79

45/57

0.2

88/107

81/97

7/10

0.7

Mean age ± SD

52.17 ± 10.27

50.69 ± 10.60

54.52 ± 9.29

0.002a

51.62 ± 10.89

51.15 ± 11.16

56.47 ± 5.86

0.05a

BMI (mean ± SD)

24.6 ± 3.1

24.2 ± 2.9

25.2 ± 3.3

0.03a

24.5 ± 3.5

24.5 ± 3.6

24.5 ± 2.7

0.9a

Viral load (×10 6 )

12.1 ± 16.4

11.0 ± 16.5

13.9 ± 16.2

0.001a

11.0 ± 19.0

10.3 ± 17.8

18.4 ± 27.9

0.3a

  1. SVR, sustained virological response; BMI, body mass index.
  2. aMann–Whitney U test.